DNA Genotek, a Subsidiary of OraSure, Launches HEMAcollect™●PROTEIN for Proteomic Research

Reuters
07/10
DNA Genotek, a Subsidiary of OraSure, Launches HEMAcollect™●PROTEIN for Proteomic Research

OraSure Technologies, Inc. has launched a new product through its subsidiary, DNA Genotek, to advance proteomic research. The product, HEMAcollect™●PROTEIN, is an evacuated blood collection tube designed to preserve and stabilize plasma proteins in whole blood for up to seven days. This innovation, intended for research use, aims to overcome limitations of conventional blood collection tubes by facilitating storage and transport of blood samples at ambient temperature. This development promises to deliver operational and financial efficiencies to proteomic researchers and enhance the quality of data generated. The device is compatible with various proteomic technologies, including mass spectrometry and immunoassays, and is applicable in multiple research areas such as oncology and neurology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OraSure Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9491972-en) on July 10, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10